Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO in AMI
NCT00882466Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- May 2008
- Primary completion
- Feb 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epoetin alfa in acute myocardial infarction (AMI) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Creatinine kinase (CK), creatinine kinase-MB (CK-MB). Started May 2008; status: completed.
02
Drugs
epoetin alfa
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT00882466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882466.